The John F. Kennedy Library and Museum Foundation shared two photos from the ceremony, congratulating President Kennedy’s ...

Only two men can tell us if Elon Musk and Trump are truly, as of December 2025, “friends.” But the formal definition I used ...

Ultragenyx and Mereo BioPharma hit 52-week low after disappointing results from Phase 3 studies for Osteogenesis Imperfecta ...

The new analysis study showed the delay may stem from genetic mutations that are present when a child is born – but activate ...

Recursion Pharmaceuticals Inc. (NASDAQ:RXRX) is one of the most active US stocks to buy according to analysts. On December 8, ...

An in-depth look at Tianqiao Chen's argument that AI-native companies will dismantle traditional corporate structures, ...

A recent article in JAMA Internal Medicine describes a common genetic mutation found in many breast cancer patients who do not have a family history of the | Cancer ...

Ultragenyx Pharma announces phase 3 Orbit & Cosmic results for setrusumab in osteogenesis imperfecta: Novato, California Wednesday, December 31, 2025, 18:00 Hrs [IST] Ultragenyx P ...

Recursion Pharmaceuticals Inc. (NASDAQ:RXRX) is one of the AI stocks under $20 to buy now. On December 8, Recursion ...

Flu season arrives with the holidays, as parties and travel kick into high gear and colder weather sets in across many states ...

Orcas have spent the past few years rewriting their public image from charismatic performers to unpredictable disruptors, ...

New AI research tool can predict plasma cell cancer outcomes instantly by reading standard biopsy slides, boosting precision ...